Growth Metrics

Pfizer (PFE) Treasury Shares (2016 - 2026)

Pfizer has reported Treasury Shares over the past 18 years, most recently at $115.2 billion for Q1 2026.

  • Quarterly Treasury Shares changed 0.16% to $115.2 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $115.2 billion through Mar 2026, changed 0.16% year-over-year, with the annual reading at $115.0 billion for FY2025, 0.22% changed from the prior year.
  • Treasury Shares was $3.9 billion for Q1 2026 at Pfizer, roughly flat from $3.9 billion in the prior quarter.
  • Over five years, Treasury Shares peaked at $3.9 billion in Q1 2026 and troughed at $39.0 million in Q2 2022.
  • The 5-year median for Treasury Shares is $3.9 billion (2024), against an average of $3.7 billion.
  • Year-over-year, Treasury Shares increased 2.34% in 2022 and then grew 0.16% in 2026.
  • A 5-year view of Treasury Shares shows it stood at $114.0 billion in 2022, then grew by 0.45% to $114.5 billion in 2023, then grew by 0.24% to $114.8 billion in 2024, then grew by 0.22% to $115.0 billion in 2025, then rose by 0.15% to $115.2 billion in 2026.
  • Per Business Quant, the three most recent readings for PFE's Treasury Shares are $115.2 billion (Q1 2026), $115.0 billion (Q4 2025), and $115.0 billion (Q3 2025).